Sarah E. Thordsen, MD, FACC

Publications

• Appropriateness of Cardiac Troponin Testing: Insights from the Use of TROPonin In Acute coronary syndromes (UTROPIA) Study.

  (Sandoval Y, Gunsolus IL, Smith SW, Sexter A, Thordsen SE, Carlson MD, Johnson BK, Bruen CA, Dodd KW, Driver BE, Jacoby K, Love SA, Moore JC, Scott NL, Schulz K, Apple FS.) Am J Med. 2019 Jul;132(7):869-874 PMID: 30849383 SCOPUS ID: 2-s2.0-85064218118 03/09/2019

• Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I.

  (Sandoval Y, Smith SW, Sexter A, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, Driver BE, Hu Y, Jacoby K, Johnson BK, Love SA, Moore JC, Schulz K, Scott NL, Apple FS.) Am J Med. 2017 Dec;130(12):1431-1439.e4 PMID: 28739197 SCOPUS ID: 2-s2.0-85027689487 07/26/2017

• Diagnostic Performance of High Sensitivity Compared with Contemporary Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction.

  (Sandoval Y, Smith SW, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, Driver BE, Jacoby K, Johnson BK, Love SA, Moore JC, Sexter A, Schulz K, Scott NL, Nicholson J, Apple FS.) Clin Chem. 2017 Oct;63(10):1594-1604 PMID: 28701316 SCOPUS ID: 2-s2.0-85030772648 07/14/2017

• Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk.

  (Sandoval Y, Thordsen SE, Smith SW, Schulz KM, Murakami MM, Pearce LA, Apple FS.) Eur Heart J Acute Cardiovasc Care. 2014 Dec;3(4):317-25 PMID: 24965188 SCOPUS ID: 2-s2.0-84965091397 06/27/2014

• Supply/demand type 2 myocardial infarction: should we be paying more attention?

  (Sandoval Y, Smith SW, Thordsen SE, Apple FS.) J Am Coll Cardiol. 2014 May 27;63(20):2079-2087 PMID: 24632278 SCOPUS ID: 2-s2.0-84901008746 03/19/2014